
OraSure Technologies OSUR
$ 3.11
0.97%
Annual report 2025
added 03-09-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
73.5 M |
Market Cap[1] |
$ 229 M |
EBITDA (LTM) |
$ -47 M |
P/E (LTM) |
-4.28 |
P/S (LTM) |
1.77 |
EPS (LTM) |
-0.72 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Harvard Bioscience
HBIO
|
$ 5.1 | -4.59 % | $ 226 M | Nasdaq Global Market | ||
|
Repro Med Systems
KRMD
|
$ 4.33 | -2.26 % | $ 200 M | Nasdaq Capital Market | ||
|
ICU Medical
ICUI
|
$ 129.29 | -0.49 % | $ 3.19 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 109.44 | 1.46 % | $ 2.48 B | Nasdaq Global Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.5 | 0.03 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 67.86 | -0.4 % | $ 4.01 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.04 | 0.85 % | $ 4.37 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 49.65 | 3.55 % | $ 163 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.61 | 0.09 % | $ 25.7 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Repligen Corporation
RGEN
|
$ 116.65 | 0.26 % | $ 6.5 M | Nasdaq Global Select Market,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
STERIS plc
STE
|
$ 223.45 | 1.11 % | $ 22 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.02 | -2.89 % | $ 31.4 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 57.23 | -2.1 % | $ 2.88 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 16.63 | 0.12 % | $ 8.53 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 106.62 | 0.61 % | $ 4.76 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 21.21 | 1.34 % | $ 1.43 B | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 10.46 | -2.33 % | $ 427 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 470.26 | -1.63 % | $ 168 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.41 | -1.24 % | $ 1.4 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.52 | -0.83 % | $ 197 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 65.56 | 0.66 % | $ 238 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 118.61 | 0.4 % | $ 3.8 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.66 | 2.53 % | $ 906 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.31 | 9.44 % | $ 24.7 M | NYSE American | ||
|
electroCore
ECOR
|
$ 6.2 | 1.14 % | $ 52.6 K | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.28 | 0.06 % | $ 14 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 246.03 | 1.92 % | $ 17.8 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 105.55 | -1.21 % | $ 5.11 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 230.33 | 1.04 % | $ 33.6 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.49 | -1.19 % | $ 25.4 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.73 | 0.69 % | $ 21.9 M | NYSE American | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.64 | 0.87 % | $ 2.32 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 19.01 | 2.7 % | $ 942 M | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.77 | -3.8 % | $ 161 M | NYSE American | ||
|
Becton, Dickinson and Company
BDX
|
$ 156.2 | -0.02 % | $ 44.9 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 74.07 | -0.09 % | $ 40.4 B | NYSE |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.